Moments That Count has been developed and funded by Novartis Pharmaceuticals UK Limited and is intended for a UK general public audience.

There is help out there

Meet Mary, Jo, Laura, Claire and Juliet

From the beginning, Moments That Count has been created with insights from real breast cancer patients. Jo, Laura, Claire, Juliet and Mary have been a great help in bringing you this information, so take a look at their individual stories to find some inspiration to take with you on your own journey.

replace me

Learn more about...

appointment guide

Appointment guide

Download now for tips and advice on how to make the most of your appointments.

Download the guide
crucial conversations meeting

Crucial conversations in breast cancer

Watch our Novartis-funded panel discuss… the importance of two-way dialogue in breast cancer care.

Watch now
terminology guide

Terminology guide

Use our glossary of medical terminology so you’re not left in the dark at appointments.

Download the guide

UK | September 2023 | 163505-1

 

 

 

 

Moments That Count Logo

Terms of use | Cookies and Data Privacy | Cookie Settings

Moments That Count has been developed and funded by Novartis Pharmaceuticals UK Limited. It has been created in collaboration with secondary breast cancer patients whose knowledge and insights have informed the content and direction for the campaign.

This website is part of a programme that is funded by Novartis Pharmaceuticals UK Limited. Novartis Pharmaceuticals UK Limited is a private limited liability company registered in England and Wales under number 119006. Registered office 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ. Use of this website is governed by our Terms of Use and the Cookies and Privacy Policy.

Reporting side-effects
If you get side effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the information leaflet that comes in the pack. You can report side effects via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of your medication.

©2024 Novartis Pharmaceuticals UK Ltd - UK | January 2024 | 124182-3 This site is intended for a UK general public audience.